The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Ohio’s businesses are the cornerstone of our state’s economy, and as someone who believes in keeping government out of the ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

We view Cigna's pharmaceutical benefit management business (bolstered through the Express Scripts merger and now called Evernorth) as competitively advantaged in its own right. With the top three ...

President Biden and Vice President Kamala Harris pretended to be anti-pharma but have taken over $10 million combined from ...

The new platform services subscription contract with a top six U.S. pharma client marks a pivotal shift in Dario's pharma ...

On July 31, 2024, Adial announced that, after an extensive review of data and information from the Onward Study, it had filed a new patent application to protect core assets and extend IP exclusivity ...

Sigma Planning Corp’s holdings in Vertex Pharmaceuticals were worth $1,277,000 at the end of the most recent reporting period. Other institutional investors also recently modified their holdings of ...

Adults with hypoparathyroidism treated with TransCon PTH in the phase 3 PaTHway open-label trial extension demonstrated ...

Nov. 12, 2024 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (OTC ... clinical trial with longer ELX-02 treatment duration to validate the observed clinical benefit in NMAS patients. The demonstrated ...

Commercial launch of neffy®(epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by ...